Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2008
12/31/2008EP2007741A1 Enantiomerically pure s-etifoxine, pharmaceutical compositions thereof and methods of their use
12/31/2008EP2007724A1 Piperidine derivatives for treatment of alzheimer's disease
12/31/2008EP2007717A1 Novel sulfonamide compounds
12/31/2008EP2007709A2 Crystal forms of o-desmethylvenlafaxine
12/31/2008EP2007479A2 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them
12/31/2008EP2007414A2 Compositions and methods for suppression of amyloid plaque formation associated with neurodegenerative disorders.
12/31/2008EP2007412A2 Therapeutic target molecules for the development of novel medicaments for degenerative diseases
12/31/2008EP2007388A2 Opiopathies
12/31/2008EP2007385A2 Cardiovascular composition and use the same for the treatment of alzheimers disease
12/31/2008EP2007373A2 Inhibition of alpha-synuclein toxicity
12/31/2008EP2007371A1 Lactate and calcium containing pharmaceutical composition and uses thereof
12/31/2008EP2007369A2 Use of rasagiline for the treatment of restless legs syndrome
12/31/2008EP2007365A2 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith
12/31/2008EP2007352A1 Treatment of psychiatric patients with sleep disturbances an/or excessive daytime sleepiness with paliperidone
12/31/2008EP2007206A2 Method and composition for protecting neuronal tissue from damage induced by elevated glutamine levels
12/31/2008EP1896489B1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof
12/31/2008EP1626727B1 Use of 2-cyano-10- (2-methyl-3- (methylamino)- propyl) phenothiazine or a pharmaceutically acceptable salt thereof as a medicament
12/31/2008EP1581219B1 Treatment of psychostimulant addiction
12/31/2008EP1558230B1 Spirocyclopropyl amides and acids and their therapeutic applications
12/31/2008EP1534823A4 The use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates
12/31/2008EP1513922B1 Pasteurisation process for microbial cells and microbial oil
12/31/2008EP1492506B1 Matrix for sustained, invariant and independent release of active compounds
12/31/2008EP1490409B1 Modified saccharides having improved stability in water
12/31/2008EP1443960B1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
12/31/2008EP1436264B1 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
12/31/2008EP1425403B1 Lentiviral vectors for the treatment of pain
12/31/2008EP1416842B1 Pharmaceutical combinations of oxycodone and naloxone
12/31/2008EP1409483B1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors
12/31/2008EP1406867B1 Thiolalkyl benzoic acid derivatives
12/31/2008EP1392261B1 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
12/31/2008EP1203239B1 Use of a polypeptide for detecting a pathological condition associated with multiple sclerosis
12/31/2008EP1192125B1 Mono-substituted 3-propyl gamma-aminobutyric acids
12/31/2008EP1102588B1 Pharmaceutical compositions for the prevention and treatment of central nervous system disorders comprising a nicotine analog and an acetylcholinesterase inhibitor
12/31/2008CN101336251A Neuregulin variants and methods of screening and using thereof
12/31/2008CN101336239A Substituted oxindol-derivatives, medicaments containing said derivatives and use thereof
12/31/2008CN101336238A Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides
12/31/2008CN101336230A Pharmaceutical for use in the treatment of ureterolithiasis
12/31/2008CN101336226A Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
12/31/2008CN101336109A Method and composition for treating and diagnosing restless legs syndrome
12/31/2008CN101336106A Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
12/31/2008CN101333256A Human antibodies that bind human il-12 and methods for producing
12/31/2008CN101333192A Biaryl substituted pyrazoles as sodium channel blockers
12/31/2008CN101333189A Aripiprazole crystal form suitable for pharmaceutical use, preparation method and pharmaceutical compositions
12/31/2008CN101333184A Processes for the preparation of (r)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4 piperidinemethanol
12/31/2008CN101333174A N-bridged selective androgen receptor modulators and methods of use thereof
12/31/2008CN101332292A Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain
12/31/2008CN101332289A Health product for facilitating alcohol metabolism and protecting liver and preparation method thereof
12/31/2008CN101332264A 'Yizhi' capsule for enhancing willpower
12/31/2008CN101332258A Medicine composition with tranquilization function
12/31/2008CN101332257A Medicine composition for preventing the birth defect and improving the memory
12/31/2008CN101332244A Oral traditional Chinese medicine for treating diffused neurodermatitis
12/31/2008CN101332241A Medicinal wine for treating apoplectic sequela and hemiparalysis
12/31/2008CN101332235A Magnolia bark and processing technique
12/31/2008CN101332234A Traditional Chinese medicine preparation for treating neurasthenic
12/31/2008CN101332221A Combination method of capsule for treating insomnia and production technique
12/31/2008CN101332211A Leech extract and preparation method and use thereof
12/31/2008CN101332209A Compound amino acid injection for treating hepatic encephalopathy
12/31/2008CN101332205A Antidepressant drug using paeoniflorin as raw material and production method thereof
12/31/2008CN101332200A New use of tripchlorolide,T4
12/31/2008CN101332193A Preparation method of fluvoxamine maleate medicine composition
12/31/2008CN101332189A Improved gastrodine effervescence tablet and preparation method thereof
12/31/2008CN101332036A Natural plant health preserving pillow
12/31/2008CN101331943A Production method of freeze-dry instant health wood-frog oil
12/31/2008CN101331906A Drink containing Congrong and coffee
12/31/2008CN100447154C Use of HMG fragments as anti-inflammatory agents
12/31/2008CN100447153C Preparing process and application of undecapeptide
12/31/2008CN100447141C Hetero-bicyclic crf antagonists
12/31/2008CN100447140C 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands
12/31/2008CN100447136C New spirotricyclic derivatives and their use as phosphodiesterase-7-inhibitors
12/31/2008CN100446792C Chinese medicine for improving memory
12/31/2008CN100446791C Chinese medicinal composition for treating hemorrhagic brain contusion and laceration
12/31/2008CN100446776C Superoxide anion decomposing agent
12/31/2008CN100446767C Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods
12/31/2008CN100446759C Gastrodine tablets disintegrating in oral cavity and process for producing same
12/31/2008CA2699961A1 N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugs
12/31/2008CA2692309A1 Improving memory in subjects with mini-mental state examination of 24-26
12/31/2008CA2691963A1 Neural stem cells
12/31/2008CA2691415A1 Tpp ii inhibitors for use in the treatment of autoimmune and inflammatory diseases and transplant rejection
12/31/2008CA2691371A1 Duloxetine formulation
12/31/2008CA2691220A1 Remedy or preventive for integration dysfunction syndrome
12/31/2008CA2691194A1 Polycyclic guanine derivatives and methods of use thereof
12/31/2008CA2691054A1 Combinations of sap depleting agents and anti-sap antibodies
12/31/2008CA2691005A1 Compositions comprising tryptophan hydroxylase inhibitors
12/31/2008CA2690975A1 Isoxazole-imidazole derivatives
12/31/2008CA2689408A1 Use of antibodies against the cd52 antigen for the treatment of neurological disorders, particularly transmissible spongiform encephalopathy and alzheimer's disease
12/31/2008CA2689350A1 Treatment of depression
12/31/2008CA2689299A1 Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
12/30/2008US7470710 Such as 2-Benzofuranylmethyl-1-((5-(4-fluorophenyl)-2-methyl-thiazolyl) carbonyl)piperidine; obesity, type 2 diabetes, sleep disorders; strokes, blocking emetic response
12/30/2008US7470704 Benzonaphthyridines
12/30/2008US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance
12/30/2008US7470695 N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
12/30/2008US7470687 Aryl oximes
12/30/2008US7470686 e.g. 1,3-benzothiazol-2-yl (2-chloral -4-pyrimidinyl)acetonitrile; Jun N -terminal kinase inhibitor; anticarcinogenic agent; neuronal disorders, autoimmune diseases, cardiovascular disordres
12/30/2008US7470685 e.g. 1-(2-(4-(N'-(3-Methyl-benzylidene)-hydrazino)-6-morpholin-4-yl-pyrimidin-2 -yloxy)-ethyl)-1H-pyridin-2-one; control interleukin production; antiinflammatory, antidiabetic agent; interleukin IL-12 overproduction-related disorder: rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis
12/30/2008US7470681 Pyrimidine compounds
12/30/2008US7470680 4-(2-Oxo-1,4-dihydro-2H-quinazolin-3-yl)-piperidine-1-carboxylic acid (9-benzyl-8-oxo-3,6,7,8,9,10-hexahydro-2,3,9-triaza-(R)-cyclohepta[e]inden-7-yl)-amide; calcitonin gene-related peptide receptor antagonist; analgesic, antiinflammatory agent; migraine, neurogenic vasodilation, menopause, asthma
12/30/2008US7470679 Constrained compounds as CGRP-receptor antagonists
12/30/2008US7470673 Using vector comprising nucleotide sequences coding atonal-associated polypetides as therapeutic tool in treating hearing impairment and inflammatory bone disorders; antiarthritic agents
12/30/2008US7470661 Delivery of superoxide dismutase to neuronal cells
12/30/2008US7470527 Preparation of microbial oil